Lazard Asset Management »

Protalix Biotherapeutics shares owned by Lazard Asset Management

Quarter-by-quarter ownership of Protalix Biotherapeutics (PLX) shares owned by Lazard Asset Management from 13F filings

Historical chart of Lazard Asset Management investment in Protalix Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Protalix Biotherapeutics held by Lazard Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Protalix Biotherapeutics by Lazard Asset Management

Quarter filed Position value Share count Share price at filing
2025-03-31 $2.0k 797 2.51
2024-12-31 $2.0k 1.3k 1.59